RESOLUTION THERAPEUTICS LIMITED

Active London

Research and experimental development on biotechnology

68 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
R

RESOLUTION THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 14 Dec 2017 Active London, England 68 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

SYNCONA COLLABORATION (E) LIMITED 14 Dec 2017 — 30 Jul 2020
Accounts Submitted 7 Nov 2025 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 15 Apr 2026 Next due 14 Feb 2027 8 months remaining
Net assets £8M £4M 2024 year on year
Total assets £21M £2M 2024 year on year
Total Liabilities £13M £2M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

245 Hammersmith Road London W6 8PW England

Website

www.example.com

Full company profile for RESOLUTION THERAPEUTICS LIMITED (11112568), an active life sciences and medical technology company based in London, England. Incorporated 14 Dec 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type group
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Balance Sheet & P&L (2018–2024)

Cash in Bank

£15.21M

Increased by £1.39M (+10%)

Net Assets

£7.57M

Increased by £3.52M (+87%)

Total Liabilities

£13.02M

Decreased by £1.71M (-12%)

Turnover

£277.90k

Employees

68

Decreased by 2 (-3%)

Debt Ratio

63%

Decreased by 15 (-19%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Dec 2020Series A, Series B

Share Capital

Share Capital

Share allotments and capital structure

17 Allotments 137,311,916 Shares £110.22m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Jul 202531,280,716£25.02m£0.8
1 Jul 2025863,849£0£0
16 Apr 20252,622,572£576.966£0
30 Sept 202431,280,716£25.02m£0.8
30 Sept 20243,924,254£0£0

Officers

Officers

1 active 2 resigned
Status
Hodgkin, Edward EliotDirectorBritishEngland6214 Dec 2017Active

Shareholders

Shareholders (89)

Syncona Portfolio Limited
36.5%
37,942,026
Syncona Portfolio Limited
30.1%
31,280,716

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Syncona Limited

British Channel Islands

Active
Notified 14 Dec 2017
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

RESOLUTION THERAPEUTICS LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
245 Hammersmith Road, London (W6 8PW) HAMMERSMITH AND FULHAM
Leasehold-11 Jul 2023
245 Hammersmith Road, London (W6 8PW)
Leasehold
Added 11 Jul 2023
District HAMMERSMITH AND FULHAM

Documents

Company Filings

DateCategoryDescriptionDocument
15 Apr 2026Confirmation StatementConfirmation statement made on 31 Jan 2026 with updates
9 Apr 2026CapitalAllotment of shares (GBP 1,040.63343) on 11 Feb 2026
25 Mar 2026OfficersAppointment of Mr Gonzalo Andres Garcia Gajardo as director
13 Mar 2026CapitalAllotment of shares (GBP 1,040.63343) on 11 Feb 2026
10 Feb 2026OfficersAppointment of Mr Gonzalo Andres Garcia Gajardo as director
15 Apr 2026 Confirmation Statement

Confirmation statement made on 31 Jan 2026 with updates

9 Apr 2026 Capital

Allotment of shares (GBP 1,040.63343) on 11 Feb 2026

25 Mar 2026 Officers

Appointment of Mr Gonzalo Andres Garcia Gajardo as director

13 Mar 2026 Capital

Allotment of shares (GBP 1,040.63343) on 11 Feb 2026

10 Feb 2026 Officers

Appointment of Mr Gonzalo Andres Garcia Gajardo as director

Recent Activity

Latest Activity

Confirmation statement made on 31 Jan 2026 with updates

1 months ago on 15 Apr 2026

Allotment of shares (GBP 1,040.63343) on 11 Feb 2026

2 months ago on 9 Apr 2026

Appointment of Mr Gonzalo Andres Garcia Gajardo as director

2 months ago on 25 Mar 2026

Allotment of shares (GBP 1,040.63343) on 11 Feb 2026

3 months ago on 13 Mar 2026

Appointment of Mr Gonzalo Andres Garcia Gajardo as director

4 months ago on 10 Feb 2026